General medicine

European Medicines Agency recommends suspension of marketing authorisations for meprobamate-containing medicines in the European Union

The European Medicines Agency has recommended the suspension of all marketing authorisations for meprobamate-containing medicines for oral use in the European Union, because their risks, particularly the risk of serious side effects affecting the nervous system, are greater than their benefits.
Read more

 http://www.ema.europa.eu/ema/index.jsp?curl=pages/news_and_e...

EMA - European Medicines Agency